Number of the records: 1  

The Bordetella pertussis Type III Secretion System Tip Complex Protein Bsp22 Is Not a Protective Antigen and Fails To Elicit Serum Antibody Responses during Infection of Humans and Mice

  1. 1.
    SYSNO ASEP0424231
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleThe Bordetella pertussis Type III Secretion System Tip Complex Protein Bsp22 Is Not a Protective Antigen and Fails To Elicit Serum Antibody Responses during Infection of Humans and Mice
    Author(s) Romero, Rodrigo, Villarino (MBU-M) RID
    Bíbová, Ilona (MBU-M) RID
    Černý, Ondřej (MBU-M)
    Večerek, Branislav (MBU-M) RID, ORCID
    Wald, Tomáš (MBU-M) RID
    Benada, Oldřich (MBU-M) ORCID, RID
    Zavadilová, J. (CZ)
    Osička, Radim (MBU-M) RID, ORCID
    Šebo, Peter (MBU-M) RID, ORCID
    Source TitleInfection and Immunity. - : American Society for Microbiology - ISSN 0019-9567
    Roč. 81, č. 8 (2013), s. 2761-2767
    Number of pages7 s.
    Languageeng - English
    CountryUS - United States
    KeywordsADENYLATE CYCLASE-HEMOLYSIN ; T-CELL EPITOPES ; IMMUNE-RESPONSES
    Subject RIVEC - Immunology
    R&D ProjectsGAP302/11/0580 GA ČR - Czech Science Foundation (CSF)
    GAP302/11/1940 GA ČR - Czech Science Foundation (CSF)
    Institutional supportMBU-M - RVO:61388971
    UT WOS000321622700012
    EID SCOPUS84880648112
    DOI10.1128/IAI.00353-13
    AnnotationThe type III secretion system (T3SS) of pathogenic bordetellae employs a self-associating tip complex protein Bsp22. This protein is immunogenic during infections by Bordetella bronchiseptica and could be used as a protective antigen to immunize mice against B. bronchiseptica challenge. Since low-passage clinical isolates of the human pathogen Bordetella pertussis produce a highly homologous Bsp22 protein (97% homology), we examined its vaccine and diagnostic potential. No Bsp22-specific antibodies were, however, detected in serum samples from 36 patients with clinically and serologically confirmed whooping cough disease (pertussis syndrome). Moreover, although the induction of Bsp22 secretion by the laboratory-adapted 18323 strain in the course of mice lung infection was observed, the B. pertussis 18323-infected mice did not mount any detectable serum antibody response against Bsp22. Furthermore, immunization with recombinant Bsp22 protein yielded induction of high Bsp22-specific serum antibody titers but did not protect mice against an intranasal challenge with B. pertussis 18323. Unlike for B. bronchiseptica, hence, the Bsp22 protein is nonimmunogenic, and/or the serum antibody response to it is suppressed, during B. pertussis infections of humans and mice
    WorkplaceInstitute of Microbiology
    ContactEliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
    Year of Publishing2014
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.